Baltimore, MDNCT07166081Now EnrollingIRB Ready

Non-diabetic Overweight or Obese Clinical Trial in Baltimore, MD

Access cutting-edge non-diabetic overweight or obese treatment through this clinical trial at a research site in Baltimore. Study-provided care at no cost to qualified participants.

Sponsored by BrightGene Bio-Medical Technology Co., Ltd.

Quick Self-Assessment

See if you qualify for this Baltimore location

Preparing your pre-screening questions…

Expert Care in Baltimore

Access non-diabetic overweight or obese specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related non-diabetic overweight or obese treatment provided free

Apply for This Baltimore Location

Check if you qualify for this non-diabetic overweight or obese clinical trial in Baltimore, MD

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Baltimore

    Convenient for MD residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Baltimore site if eligible
  4. 4Begin participation

About This Non-diabetic Overweight or Obese Study in Baltimore

This is a Phase 1, single-center, randomized, placebo-controlled, ascending dose study. The study will evaluate the pharmacokinetics (PK), pharmacodynamic (PD), preliminary efficacy, safety and tolerability of BGM0504 following daily oral administrations in non-diabetic overweight or obese adult subjects.

Sponsor: BrightGene Bio-Medical Technology Co., Ltd.

Who Can Participate

Inclusion Criteria

Body mass index (BMI) meeting one of the following requirements:
Between ≥ 30.0 kg/m2 and ≤ 40.0 kg/m2 (obese); OR
Between ≥ 27.0 kg/m2 and \< 30.0 kg/m2 (overweight) with at least 1 of the following: One or more symptoms of prediabetes (impaired fasting plasma glucose and/or abnormal glucose tolerance), grade 1 hypertension, simple fatty liver or dyslipidemia
Have a stable body weight (\<5% self-reported change during the previous 12 weeks) before screening
Capable of understanding the written informed consent document; willingly provides valid, signed written informed consent; willing and able to comply with the schedule, requirements and restrictions of the study.

Exclusion Criteria

Have allergic predisposition (allergic to 3 or more foods or drugs), or are allergic to glucagon-like peptide-1 (GLP-1) receptor agonists or suffer from severe allergic diseases (asthma, urticaria, eczematous dermatitis).
Have received GLP-1 receptor agonists or similar drugs containing the same target within 12 weeks before screening.
Have received drugs that have an impact on body weight within 12 weeks before screening.
Known type I/II diabetes.
History of acute or chronic pancreatitis or pancreatic injury.
History of drug abuse or alcoholism at screening.

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Baltimore?

Yes, this clinical trial (NCT07166081) has an active research site in Baltimore, MD that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Non-diabetic Overweight or Obese Treatment Options in Baltimore, MD

If you're searching for non-diabetic overweight or obese treatment options in Baltimore, MD, this clinical trial (NCT07166081) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Baltimore research site is actively enrolling participants for this clinical trial. You'll receive care from experienced non-diabetic overweight or obese specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all non-diabetic overweight or obese clinical trials near you to find additional studies recruiting in your area.

More Essential Tremor Trials in Baltimore, MD

See all essential tremor clinical trials recruiting in Baltimore — not just this study.

Browse Essential Tremor Trials in Baltimore →

Browse More Trials by Condition

Essential Tremor TrialsType 2 Diabetes TrialsObesity TrialsInterstitial Cystitis TrialsAll Conditions →

Ready to Join in Baltimore?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Baltimore, MD